All News
Early CV changes in #Rheumatoidarthritis abst#0271 showed more subclinical atherosclerosis vs controls in ERA, Abs ⬆️MACE &CV death in RA pts, abst#0269 ex RF, ACPA, MAA. Lipids ⬆️differently in RA given #tocilizumab vs TNFi BUT unrelated to CV events abst#0269 #ACR21 @RheumNow
Janet Pope Janetbirdope ( View Tweet)
#ACR21 The Great Debate: Belimumab vs Voclosporin as Add-On Therapy in #LupusNephritis | Dr. Petri & Dr. Rovin
Audience Vote 🗳: What would you add to mycophenolate first?
Belimumab 71%, Voclosporin 29%
#ACRAmbassador @ACRheum
Summary of Pros & Cons of Each⬇️ https://t.co/OtLxs8IYr9
Mithu Maheswaranathan, MD MithuRheum ( View Tweet)
Young et al. Impact of COVID-19 on rheumatology training
302 rheumatology trainees from 33 countries surveyed
➡️52% feel burned out🔼from prior
➡️66% felt supported by their program
➡️72% felt positive about being in Rheumatology
Abst#0485 #ACR21 @RheumNow @kristenyoung
swethaann23 swethaann23 ( View Tweet)
Excellent talk by Dr. Anna Molto. Characteristics of spondyloarthritis, noting some patients with PsA have radiographic and non-radiographic axial SpA.
#ACR21 6S403 @RheumNow https://t.co/ycftOMrWO9
Pedro Castillo _Castillo_Pedro ( View Tweet)
Do you use ANCA to change Rx in prevalent GPA pts? GS401 #ACR21 @RheumNow
Janet Pope Janetbirdope ( View Tweet)
OMG, the fear of missing something due to the discordant daylight savings shift is real! https://t.co/1mi2QnrHDl
Richard Conway RichardPAConway ( View Tweet)
@kristenyoung @rheum_covid project on impact of COVID-19 on our trainees. Love the graphics by @EBRheum . Negatives are physical health, stress levels, and burnout all ⬆️ . Positives? Trainees did feel supported by programmes. Abstr#0485 #ACR21 @RheumNow https://t.co/kXQ1AUNrgb
Richard Conway RichardPAConway ( View Tweet)
Interested in the intersection of the arts/humanities and becoming a better version of yourself? If so join us for the 1st such event tomorrow AM at #ACR21 @AWIRGROUP @CleClinicLCM @GoldFdtn #empathy @CCalabreseDO @CleClinicMD @bschillace @psufka @RheumNow #humanities https://t.co/xwDF2ZLrXk
Leonard Calabrese LCalabreseDO ( View Tweet)
Leverenz et al.
@RheumMadness an online community of inquiry leading to a collaborative learning experience for fellows from 14 fellowship programs in the US
⭐️Full participants strongly agreed it fostered meaningful cognitive, social, and teaching
Abst# 0484 #ACR21 @RheumNow
swethaann23 swethaann23 ( View Tweet)
HCP #burnout coping strategies listed during 6S228 Let’s talk about mental health #ACR21 - writing, yoga, exercise, gardening, drawing& other creativity. I practice gratitude 🙏🏻 @RheumNow Burnout is real and magnified by #COVID19 pressures https://t.co/PUklM2Ci6e
Janet Pope Janetbirdope ( View Tweet)
Are we getting closer to personalised medicine in #psoriaticarthritis Predicting progressors vs non-progressors using proteomics identified 103 candidate biomarker peptides that will discriminate the two groups @RheumNow #ACR21 #ACRBest Abst#0449 https://t.co/obDXTz3i5N
Dr. Antoni Chan synovialjoints ( View Tweet)
Excellent scientific session on #SpA at #ACR21 right now- especially like this clear diagram of pathophysiology and useful summary slide from Dr Nigil Haroon on differences between #axSpA and axial #PsA
@RheumNow https://t.co/F7Ns7e9HQI
Mrinalini Dey DrMiniDey ( View Tweet)
“The differences and similarities between axial disease in psoriatic arthritis vs axial spondyloarthritis is just at the cusp of discovery” Nigil Haroon at session 6S403 @RheumNow #ACR21
Dr. Antoni Chan synovialjoints ( View Tweet)
My exclusive interview w/the GRA Powerhouse!
What are they studying next?
👉impact of COVID policies on Rheum pts
👉pt's perception w/COVID vaccines
👉COVID risk calculator
👉long haulers w/ rheum dz
👉breakthrough infections
@rheumnow https://t.co/dVLayNchHT @rheum_covid https://t.co/B1KIjxYt15
TheDaoIndex KDAO2011 ( View Tweet)
In this video, @rheumnow faculty recapped pre-ACR events, opening day lecture with @DrDavidKarp @DoctorYasmin year in review.
#ACR21 @uptoTate @RHEUMarampa
https://t.co/CO1uIyj1Z0 via @YouTube
TheDaoIndex KDAO2011 ( View Tweet)
Tyk2/Jak1 inhibitor brepocitinib in PsA. Looks good. Works for skin, joints, enthesitis, dactylitis, and PROs. No unexpected safety signals. Abstr#0488 #ACR21 @RheumNow https://t.co/MIOLw8BABN
Richard Conway RichardPAConway ( View Tweet)
Prolonging the Controversy of Hydroxychloroquine
Dr. Kathryn Dao (@KDAO2011 ) shares several abstracts from #ACR21 that addressed the topic of HCQ and cardiovascular safety.
https://t.co/J6sVzYJkUZ https://t.co/dBZmtwQ927
Links:
Dr. John Cush RheumNow ( View Tweet)
My first video for #ACR21 for @RheumNow, discussing #SickLeave, #WorkParticipation and #WorkDisability in patients with #SpA, with a focus on abstracts 0380 and 0381 by @ElenaNikiUK
#axspa #spondyloarthritis #arthritis #qualityoflife
Watch it here👇🏼
https://t.co/MEQ4wkFxrx
Mrinalini Dey DrMiniDey ( View Tweet)
#ACR21 #Abstr0252 Let's examine our patients than relying on tests. In sJIA pts presenting with fever, clinical features (fever pattern, rash and MSK symptoms) distinguished inflammation vs infection but not CRP, ferritin and procalcitonin @RheumNow https://t.co/s61WGBVK73 https://t.co/qhN95GdwgJ
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
A key reason I'm looking forward to in-person conferences again, is so I don't have to perform the mental gymnastics and stress of ensuring I make all the sessions and meetings on time! 😂
⏰UK colleagues- time difference for #ACR21 will be +5️hours from tomorrow!
@RheumNow https://t.co/wl7ij3vyOU
Mrinalini Dey DrMiniDey ( View Tweet)